Telephone: 86-571-87236570; FAX: 86-571-87236884
Article first published online: 26 OCT 2012
Copyright © 2012 American Association for the Study of Liver Diseases
Volume 18, Issue 11, pages 1316–1323, November 2012
How to Cite
Hu, Z., Wang, W., Li, Z., Ye, S. and Zheng, S.-S. (2012), Recipient outcomes of salvage liver transplantation versus primary liver transplantation: A systematic review and meta-analysis. Liver Transpl, 18: 1316–1323. doi: 10.1002/lt.23521
The experiments were conceived and designed by Zhenhua Hu, Wei Wang, and Shu-Sen Zheng. Zhenhua Hu, Wei Wang, Zhiwei Li, and Sunyi Ye performed the experiments, analyzed the data, and contributed reagents, materials, and analytical tools. Zhenhua Hu, Wei Wang, and Shu-Sen Zheng wrote the article.
This work was supported by a grant from the National Basic Research Program of China through the 973 Program (2009CB522403).
- Issue published online: 26 OCT 2012
- Article first published online: 26 OCT 2012
- Accepted manuscript online: 30 JUL 2012 06:09PM EST
- Manuscript Accepted: 11 JUL 2012
- Manuscript Received: 13 FEB 2012
- National Basic Research Program of China through the 973 Program. Grant Number: 2009CB522403
Salvage liver transplantation (SLT), or liver transplantation after liver resection (LR), has been performed after primary LR for many years. However, the true outcomes and risks of SLT versus primary liver transplantation (PLT) remain unclear. We performed a systematic review and meta-analysis to evaluate the survival rate of SLT recipients and the incidence of postoperative complications. Among 2799 screened references, 7 eligible studies were identified. The results of the meta-analysis indicated no statistically significant differences in the overall survival rates of SLT and PLT: the pooled relative risk (RR) was 0.99 [95% confidence interval (CI) = 0.90-1.09, P = 0.87] at 1 year, 0.97 (95% CI = 0.83-1.13, P = 0.68) at 3 years, and 0.96 (95% CI = 0.81-1.13, P = 0.61) at 5 years. As for postoperative complications, there were no statistically significant differences in the incidence of sepsis and biliary complications between SLT and PLT, but there was a significantly higher incidence of bleeding with SLT (RR = 2.84, 95% CI = 1.57-5.13, P = 0.001). In conclusion, the overall survival associated with SLT is similar to that associated with PLT. Because of the limited organ donor pool, SLT might be an acceptable therapy for patients undergoing primary LR for hepatocellular carcinoma. Liver Transpl 18:1316–1323, 2012. © 2012 AASLD.